RSC Pharmaceutics has published its first articles. To celebrate this, we asked the authors to discuss their work in some more detail.
In this edition, we hear from Noriho Kamiya about their study titled Exploring the molecular structure of lipids in the design of artificial lipidated antifungal proteins.
“This study follows on from our previous work (ACS Infect. Dis., 2022, 8, 1051-1061). In our attempts to enhance the function of antifungal proteins by artificial lipid modification, we have obtained new evidence that specific lengths of lipid moieties enhance the antifungal activity of the chitin-binding domain of a plant chitinase in the presence of amphotericin B. Further studies, including the development of new formulations that maximize the potent antifungal properties, are underway.”
Want to know more about their work? Read the full paper here!
Hendra Saputra, Muhammad Safaat, Kazuki Uchida, Pugoh Santoso, Rie Wakabayashi, Masahiro Goto, Toki Taira and Noriho Kamiya
RSC Pharm. 2024, Advance Article, DOI: 10.1039/D3PM00087G
 |
RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery.
|